Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.W

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by hydrocarbsson Jul 09, 2019 9:58am

83 Views

Post# 29898749

RE:RE:RE:RE:RE:RE:Ph. 2 N-803 with BCG in BCG-unresponsive NMIBC

Oh, I am invested in TLTFF. I'm south of the border.

Love this board, pull a chain, throw a little tongue in cheek up and the varied repsonses are amazing.

Do think the share price will come down once the PP is announced.

The closing under the Offering is expected to occur on or about July 22, 2019, on such other date as the Lead Agent and Company may agree. From the June 26 (late day) news release.

Other biotech stock prices have taken a hit when the pricing has been announced. I expect TLTFF to do the same and have some price targets in mind.

Had to stop mind altering substances in the late 70's. It was a life or death decision.

Bullboard Posts

Advancing an underexplored area of the Yukon with the same geology as B.C’.s Golden Triangle